TADCLOT- a Double Blind Randomized Controlled Trial
Conditions: Stent Thrombosis; Myocardial Infarction, Acute Interventions: Drug: Ticagrelor 90 MG; Drug: Clopidogrel Sponsors: National Institute of Cardiovascular Diseases, Pakistan; PharmEvo Pvt Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Clopidogrel | Heart | Heart Attack | Pakistan Health | Plavix | Research | Thrombosis